BE

CDx Diagnostics’ ​​WATS3D Participates in Highmark, Inc. Health Plans in Delaware, Pennsylvania, and West Virginia

Retrieved on: 
Thursday, May 19, 2022
Surgery, Medical Devices, Biotechnology, Other Health, Radiology, Managed Care, Health, General Health, Oncology, Cancer, Physician, Colon, Highmark, Science, Practice, Esophagus, Stomach, Society, Time, BE, Artificial intelligence, Esophageal cancer, Evidence-based medicine, Technology, Method, Medicare, AFS, Molecular biology, IBD, Gastrointestinal Endoscopy, Commercial, GERD, Dysplasia, ASGE, Diagnosis, Galen Partners, Intelligence, Society of American Gastrointestinal and Endoscopic Surgeons, Acquisition, Cdx, Marie Cassidy, American Society for Gastrointestinal Endoscopy, CEO, Medical imaging

WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to empower physicians to reliably detect Barretts esophagus (BE) and esophageal dysplasia to help prevent esophageal cancer, was designated as medically necessary by Highmark, Inc. health plans in Delaware, Pennsylvania, and West Virginia in Q4 2021.

Key Points: 
  • WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to empower physicians to reliably detect Barretts esophagus (BE) and esophageal dysplasia to help prevent esophageal cancer, was designated as medically necessary by Highmark, Inc. health plans in Delaware, Pennsylvania, and West Virginia in Q4 2021.
  • CDx Diagnostics is pleased to share, that effective immediately, WATS3D is now considered an in-network procedure as CDx Diagnostics participates in the Commercial and Medicare networks of these Highmark, Inc. plans.
  • Empowering physicians to preempt esophageal cancer and improve patient lives is what drives us.
  • Since 2019, the ASGE has included WATS3D in its Standards of Practice Committees guideline for the screening and surveillance of BE.

Akerna Announces Adjournment of Annual Meeting of Stockholders

Retrieved on: 
Friday, May 13, 2022
U.S. Securities and Exchange Commission, Common stock, Form 10-K, ANY, Proxy, Proxy statement, Private Securities Litigation Reform Act, Face, SEC, Risk, Capital, MORE, Annual general meeting, Cannabis, Trellis, Attention, Board, Software as a service, Acquisition, GLOBE, Company, Annual, AND, THE, Annual Meetings of the International Monetary Fund and the World Bank Group, CBD, Annual report, Nasdaq, Patient, BE, Industry, AS, Person, Online gambling, Holding company, Security (finance), Drug

DENVER, May 13, 2022 (GLOBE NEWSWIRE) -- Akerna Corp. (Nasdaq: KERN) (“Akerna”) announced today that its 2022 annual meeting of stockholders (the “Annual Meeting”) has been adjourned to Monday, May 23, 2022 at 9 a.m. Mountain Time with respect to all proposals described in Akerna’s definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 19, 2022 (the “Proxy Statement”).

Key Points: 
  • During the current adjournment, Akerna continues to solicit votes from its stockholders with respect to all proposals set forth in the Proxy Statement.
  • Proxies previously submitted with respect to the Annual Meeting will be voted on all proposals at the adjourned Annual Meeting unless properly revoked, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
  • Such forward-looking statements include but are not limited to statements regarding the date of the Companys annual meeting of stockholders and statements regarding the benefits of voting for the proposals at the Companys annual general meeting of stockholders.
  • In connection with the annual meeting of stockholders, the Company filed with theSecurities and Exchange Commission(SEC) a definitive proxy statement which was mailed to the Companys stockholders as of the record date for the annual meeting of stockholders.

Unicycive Announces First Quarter Financial Results and Provides Business Update

Retrieved on: 
Thursday, May 12, 2022
Chronic kidney disease, CKD, Population, Company, Hyperphosphatemia, Stanford University School of Medicine, Research, Roth Capital Partners, Nasdaq, Patient, Poster, File, Nephrology, Insurance, Therapy, Liver, Clinical trial, Eye, MPH, Kidney, BE, FDA, IND, Kidney disease, Mitochondrial disease, AKI, Population health, Biotechnology, Conditional sentence, Heart, Acute kidney injury, NDA, European Renal Association – European Dialysis and Transplant Association, Mitochondrion, LOS, GLOBE, Pharmaceutical industry, Medicine

LOS ALTOS, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the first quarter ended March 31, 2022 and provided a business update.

Key Points: 
  • LOS ALTOS, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc.(Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the first quarter ended March 31, 2022 and provided a business update.
  • Throughout the first quarter, we continued to make meaningful progress to advance and expand the clinical development of our lead product candidates.
  • Unicycive plans to enroll the first subject in a bioequivalence (BE) study in healthy volunteers to demonstrate the comparability of Renazorb to the reference listed drug, Fosrenol, in the second quarter.
  • General and administrative expenses for the quarter ended March 31, 2022 were $1.6 million, compared to $0.3 million for the same quarter in 2021.

500 Global and Sanabil Investments announce Batch 3 of the Sanabil 500 MENA Seed Accelerator

Retrieved on: 
Tuesday, May 10, 2022
Professional Services, Technology, Small Business, Other Technology, Finance, Banking, Ecosystem, Diet, YouTube, ALL, Fairmont Hotels and Resorts, MENA, Y, SELL, Economic development, WITH, BE, AN, OF, Education, Non-fungible token, Seed, Goal, L.L.C, Solution, Technology, Fairmont Hotel, GCC, Growth, THE, Multimedia, Financial services, Weapon, Cryptocurrency, Public relations, Online shopping, Global

500 Global, a leading global venture capital firm, and Sanabil Investments, a financial investment company focused on global private investments in venture capital, growth and small buyouts, unveiled today 14 startups in Batch 3 of the Sanabil 500 MENA Seed Accelerator Program 2022.

Key Points: 
  • 500 Global, a leading global venture capital firm, and Sanabil Investments, a financial investment company focused on global private investments in venture capital, growth and small buyouts, unveiled today 14 startups in Batch 3 of the Sanabil 500 MENA Seed Accelerator Program 2022.
  • They were selected out of more than 500 applicants from MENA which represents an acceptance rate of less than 3%.
  • Nearly 40 companies have graduated so far from the Sanabil 500 MENA Seed Accelerator since its launch a year ago.
  • (TOGETHER WITH ITS AFFILIATES, 500 GLOBAL) AND 500 GLOBAL FUNDS DO NOT PARTICIPATE IN ANY REVENUE GENERATED BY THESE ACTIVITIES.

Akerna Corp. Reminds Stockholders of Upcoming Annual Meeting; Urges Stockholders to Vote FOR all Proposals

Retrieved on: 
Monday, May 9, 2022
Microsoft, Internet, Person, Risk, BE, Shareholder, SEC, CBD, Annual general meeting, Microsoft Dynamics 365 Business Central, FOR, LTM, Company, Patient, ANY, Industry, Cannabis, Software as a service, THE, U.S. Securities and Exchange Commission, AND, Private Securities Litigation Reform Act, Sale, AS, MORE, GLOBE, Annual report, Trellis, Form 10-K, Institutional Shareholder Services, Holding company, Security (finance), Drug, Nasdaq

Akerna common stockholders on the March 31, 2022 record date are entitled to vote.

Key Points: 
  • Akerna common stockholders on the March 31, 2022 record date are entitled to vote.
  • To vote by internet stockholders can logon to the website shown on their proxy card and follow the steps outlined on the secure website.
  • If stockholders are voting by mail, they should vote, sign and date their proxy card and return it in the postage-paid envelope provided.
  • Akerna is asking stockholders to approve the election of directors, ratification of auditors, the Nasdaq 20% Proposals, the authorized share increase, and the amendment to the 2019 Long Term Incentive Plan.

Data from Independent, Pooled Analysis Show Significantly Improved Risk Predictions Over Clinical Variables for TissueCypher® Barrett’s Esophagus Test and Ability to Identify Patients at High Risk of Progressing to Esophageal Cancer

Retrieved on: 
Wednesday, April 27, 2022
Oncology, Health, Other Science, Research, Science, Pharmaceutical, Biotechnology, Manuscript, HGD, Medicine, Endoscopy, Mayo Clinic, Pathology, Journal of Clinical Gastroenterology, Disease management, Patient, Hepatology, List of life sciences, Odds ratio, Health, Nasdaq, BE, Esophageal cancer, Clinical professor, Division, Â, Case Western Reserve University, Risk, Medical imaging, Gastroenterology

In clinical practice, the majority of BE patients who develop esophageal cancer are diagnosed as NDBE at their baseline endoscopy.

Key Points: 
  • In clinical practice, the majority of BE patients who develop esophageal cancer are diagnosed as NDBE at their baseline endoscopy.
  • In the manuscript titled, Prediction of Progression in Barretts Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies, Iyer et al.
  • Further, a TissueCypher high-risk score was associated with a strong (Odds Ratio (OR)=14.3) independent risk of progression in NDBE patients.
  • The TissueCypher Barretts Esophagus test is Castles precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with Barretts esophagus (BE).

VIAEUROPE UNVEILS NEW AUTOMATED SORTING BELT AT LIEGE e-HUB

Retrieved on: 
Saturday, April 23, 2022
Technology, Map, LinkedIn, Intention, GLOBE, Liège Airport, Atmosphere, Amsterdam Airport Schiphol, EU, Atmosphere of Earth, BE, Reading, Maintenance, AI, LGG, Investment, Warehouse

Lige, BE, 21 April 2022 To accompany its spectacular growth in Lige (LGG/Belgium),ViaEurope, a leader in e-commerce logistics in Europe, has unveiled today its new fully automated sorting belt at its LGG e-Hub.

Key Points: 
  • Lige, BE, 21 April 2022 To accompany its spectacular growth in Lige (LGG/Belgium),ViaEurope, a leader in e-commerce logistics in Europe, has unveiled today its new fully automated sorting belt at its LGG e-Hub.
  • LGG e-HUB new belt system can handle over 3.500 parcels per hour.
  • To further enhance operations, this warehouse is now expanding from 13 to 34 sorting options and has the ability to serve 34 destinations at once.
  • The recent investments made by ViaEurope in Liege confirm the companys intention to further grow at this location, together with the local community.

Boys & Girls Clubs of Bellevue to honor 14 Years of Partnership with the Robert Vasen Foundation and the Establishment of the Robert Vasen Endowment for Youth

Retrieved on: 
Thursday, April 21, 2022
RVF, Life, Club, Organization, Program, Friends, Walking, BE, Boys & Girls Club, Foundation, History, Partnership, Time, Nightclub, Medicine

BELLEVUE, Wash., April 21, 2022 /PRNewswire/ -- Boys & Girls Clubs of Bellevue (BGCB) to honor the Robert Vasen Foundation (RVF) with the Champion of Youth Award at their upcoming Gala on the evening of Saturday, April 23, 2022.

Key Points: 
  • BELLEVUE, Wash., April 21, 2022 /PRNewswire/ -- Boys & Girls Clubs of Bellevue (BGCB) to honor the Robert Vasen Foundation (RVF) with the Champion of Youth Award at their upcoming Gala on the evening of Saturday, April 23, 2022.
  • He found great joy in building community there and was passionate about helping the friends he met along the way.
  • "The Robert Vasen Foundation is truly walking the talk as unrequited Champions of Youth since 2008," said BGCB President and CEO Tim Motts.
  • Next Saturday, April 23, Boys & Girls Clubs of Bellevue will celebrate over a decade of committed partnership by presenting the Robert Vasen Foundation with the Champion of Youth Award.

Orange Restoration Labs - The Trusted Name in Cleaning, Preserving & Restoring Bridal Gowns - Attends the Association of Wedding Specialists Annual Meeting

Retrieved on: 
Wednesday, April 20, 2022
Mike Ernst, HAND, ERNST, BE, Marketing, Association, Personal protective equipment, Lace

NORWALK, Conn., April 20, 2022 /PRNewswire/ --Business partners Michael Astorino and Ernst J. Eloi acquired award-winning Orange Restoration Labs in January.

Key Points: 
  • NORWALK, Conn., April 20, 2022 /PRNewswire/ --Business partners Michael Astorino and Ernst J. Eloi acquired award-winning Orange Restoration Labs in January.
  • Mike & Ernst recently attended & presented at the Association of Wedding Gown Specialists meeting in Jacksonville, FL where business owners from around the world met to discuss best practices involving the preservation of wedding gowns.
  • The Association, founded in 1987 and run by Sally Conant (former owner of Orange Restoration Labs), is a non-profit association for specialty dry cleaners around the world.
  • The members, or Certified Wedding Gown Specialists, are trusted, highly trained experts when it comes to cleaning, restoring, and preserving wedding gowns, veils and other precious items.

Greene Concepts Updates Shareholders on Audit, Happy Mellow Launch and other Corporate Actions

Retrieved on: 
Tuesday, April 19, 2022
Issuer, Water, Lawyer, CEO, Blue Ridge Mountains, Awareness, Share repurchase, Marketing, U.S. Securities and Exchange Commission, Financial audit, Security (finance), VP, CBD, Safe harbor, GLOBE, Securities Act of 1933, Vitamin B12, OTC Markets Group, Securities Exchange Act of 1934, Growth, Form 10-K, Disclosure, Company, BE, Vitamin D3 dihydroxylase, SEC, Six pack, PCAOB, Fed, Audit, Caffeine

Lenny Greene, CEO of Greene Concepts, stated, I am extremely proud and grateful to the entire Greene Concepts team for their dedication and effort to bring us to the final part of the Companys audit.

Key Points: 
  • Lenny Greene, CEO of Greene Concepts, stated, I am extremely proud and grateful to the entire Greene Concepts team for their dedication and effort to bring us to the final part of the Companys audit.
  • The Company has also been working diligently to complete the final development stages of a marketing and launch campaign for Happy Mellow, the Companys all-natural CBD enhanced immune support beverage.
  • At which time, we will produce the first run of our highly anticipated CBD-infused immune support beverage, Happy Mellow.
  • Greene Concepts continues to develop and market premium beverage brands designed to enhance the daily lives of consumers.